Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-19

Clinical Trial Update: Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update showing recruiting status for Transcutaneous Auricular Vagus Nerve Stimulation to treat Dry Eye Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transcutaneous Auricular Vagus Nerve Stimulation

Snippet

Sponsor: Beijing Tongren Hospital | Conditions: Dry Eye Disease | Phase 2 | Status: RECRUITING